Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.
Twenty patients (mean age 52 +/- 12 years, mean weight 75 +/- 15 kg) scheduled for elective myelogram or spinal anaesthesia were enrolled to determine the cerebrospinal fluid (CSF) penetration of a new expanded spectrum cephalosporin antibiotic, cefpirome (HR-810). A single 2 g intravenous dose of cefpirome was administered as a bolus between 1 and 8 h before lumbar puncture. Blood samples were collected at 15 pre-determined times and a single CSF sample was obtained at the time of lumbar puncture. Serum and CSF cefpirome concentrations were determined by high performance liquid chromatography. The mean maximal serum concentration of cefpirome was 264 +/- 76 mg/L. A mean steady-state volume of distribution of 20 +/- 4 L, clearance of 7.4 +/- 1.3 L/h, and half-life of 2.5 +/- 0.5 h were determined. Mean CSF concentrations were 0.50 +/- 0.11 mg/L at 1-2 h post dose (n = 4), 0.57 +/- 0.13 mg/L at 2-4 h post dose (n = 4), 0.76 +/- 0.34 mg/L at 4-6 h post dose (n = 7), and 0.83 +/- 0.29 mg/L at 6-8.3 h post dose (n = 5). Blood:brain barrier permeability to cefpirome may not be a limiting factor as CSF concentrations were rapidly attained. Further studies are required to determine the mechanism of cefpirome transport between plasma and CSF.
Nix
D E
DE
Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, New York 14209.
Wilton
J H
JH
Velasquez
N
N
Budny
J L
JL
Lassman
H B
HB
Mitchell
P
P
Divan
K
K
Schentag
J J
JJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000775:Anesthesia, Spinal; D002511:Cephalosporins / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D008297:Male; D008578:Meninges / Q000378:metabolism*; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000378:metabolism; D008875:Middle Aged; D009192:Myelography; D013129:Spinal Puncture; D000097572:Cefpirome
D002511:Cephalosporins; D000097572:Cefpirome